4//SEC Filing
TOMSICEK MICHAEL JOHN 4
Accession 0001209191-20-054070
CIK 0001674416other
Filed
Oct 5, 8:00 PM ET
Accepted
Oct 6, 5:48 PM ET
Size
5.3 KB
Accession
0001209191-20-054070
Insider Transaction Report
Form 4
TOMSICEK MICHAEL JOHN
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-10-05+11,666→ 11,666 totalExercise: $86.75Exp: 2030-10-05→ Common Shares (11,666 underlying)
Footnotes (1)
- [F1]This option was granted on October 5, 2020 with respect to 11,666 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 5, 2020.
Documents
Issuer
CRISPR Therapeutics AG
CIK 0001674416
Entity typeother
Related Parties
1- filerCIK 0001570392
Filing Metadata
- Form type
- 4
- Filed
- Oct 5, 8:00 PM ET
- Accepted
- Oct 6, 5:48 PM ET
- Size
- 5.3 KB